This HTML5 document contains 68 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n9http://dx.doi.org/10.1111/
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q91620649
rdf:type
wikibase:Item
schema:description
wetenschappelijk artikel artículu científicu espublizáu en febreru de 2019 наукова стаття, опублікована в лютому 2019 scientific article published on 15 February 2019 article scientifique publié en 2019
p:P577
wds:Q91620649-FFAAF676-CBA3-4649-9875-6B9354E03A1A
wdt:P577
2019-02-15T00:00:00Z
p:P2093
wds:Q91620649-D2E0DA91-488C-4BF5-84DD-6607381D5A47 wds:Q91620649-F1644E6D-CDDF-4178-9213-24A1F73D277A
wdt:P2093
Nelson Leung Yi L Hwa
rdfs:label
Substratification of patients with newly diagnosed standard-risk multiple myeloma Substratification of patients with newly diagnosed standard-risk multiple myeloma
skos:prefLabel
Substratification of patients with newly diagnosed standard-risk multiple myeloma Substratification of patients with newly diagnosed standard-risk multiple myeloma
schema:name
Substratification of patients with newly diagnosed standard-risk multiple myeloma Substratification of patients with newly diagnosed standard-risk multiple myeloma
p:P50
wds:Q91620649-F754E04D-5BD5-46E6-913C-26D191152A72 wds:Q91620649-FCC135F3-8338-45DA-8E7E-1404BB52C3A4 wds:Q91620649-094D7463-0A5C-49CE-BA84-096EBB2D71A8 wds:Q91620649-0BFE8893-80BC-4EE3-ADBE-288B19BE07C8 wds:Q91620649-1A8DB444-475C-4DBA-AE1F-9EE36495843B wds:Q91620649-3A6848A4-F9FC-40D1-8FAA-C91B5A85C0F4 wds:Q91620649-C656D7C4-F03F-4BCD-8431-BBA00696E807 wds:Q91620649-D1F49E54-0BA4-4EF6-AC4F-075AFBB30774 wds:Q91620649-F2E82881-3B1C-4B60-B8F9-520E9B5D15EE wds:Q91620649-6FB2E04E-0B9A-4ACC-9FEE-C584EF9E3F25 wds:Q91620649-719CCF1C-8D61-4D20-8F4D-F9FADB985A8E wds:Q91620649-7B613D10-23BD-43A3-973B-80F763583648 wds:Q91620649-8E4F9860-629F-4E94-B2F2-07A325A3F5CE wds:Q91620649-9C0819D5-6D5D-448B-BBE6-6D11A1B393A2 wds:Q91620649-9C815731-7E27-4F08-AE37-2BC7793BB8B7 wds:Q91620649-BB77C7A0-8677-4FEB-915B-956D0FF15059
wdt:P50
wd:Q61123608 wd:Q37838558 wd:Q89921551 wd:Q85960198 wd:Q66419394 wd:Q84141772 wd:Q66385695 wd:Q56990716 wd:Q96475488 wd:Q96475494 wd:Q88774336 wd:Q53843820 wd:Q88037405 wd:Q46177716 wd:Q110810892 wd:Q57052163
p:P1476
wds:Q91620649-ED30C186-205D-4D45-8D7E-E75DE7FD7F7B
wdt:P1476
Substratification of patients with newly diagnosed standard-risk multiple myeloma
p:P304
wds:Q91620649-66D89310-5D8E-499B-B7BA-D6C1A07EDDC6
wdt:P304
254-260
p:P31
wds:Q91620649-D953663F-345C-4857-B410-DEE1727DF0B7
wdt:P31
wd:Q13442814
p:P698
wds:Q91620649-469153FF-A553-4778-80E1-3768AA0E4AE7
wdtn:P698
n11:30768679
wdt:P698
30768679
p:P1433
wds:Q91620649-E076C8F8-CE85-43F7-8B2F-6AAF7D456BC0
wdt:P1433
wd:Q4970200
p:P433
wds:Q91620649-9524C604-8C68-4EDC-B459-1475BAC5A1F4
p:P478
wds:Q91620649-2863CA71-CCA8-4231-9587-CB2F9AC6342C
wdt:P433
2
wdt:P478
185
p:P356
wds:Q91620649-12E2C3B0-5BB0-4E33-BF39-2542E80AFB42
wdtn:P356
n9:BJH.15800
wdt:P356
10.1111/BJH.15800